Schedule 13G ownership disclosure
Nabriva Therapeutics AG
Security class unavailable · CUSIP: 62957M104
Event date: 2015-09-18
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 15.9100%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001193125-15-329003
- Form type
- SC 13G
- Filer
- Nabriva Therapeutics plc
- CIK
- CIK 1641640
- Filed
- Sep 25, 2015
- Reporting period
- Sep 18, 2015
- Description
- Schedule 13G beneficial ownership